Debra Frimerman - Mar 1, 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)

Signature
Suzette McNally, Attorney-in-Fact for Debra Frimerman
Stock symbol
CBUS
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 08:25 PM
Previous filing
Jan 4, 2023
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBUS Common Stock Award $0 +5.53K +41.79% $0.00 18.8K May 31, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -80K -100% 0 Mar 1, 2023 Common Stock 80K $4.55 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Award +80K 80K Mar 1, 2023 Common Stock 80K $4.55 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -27K -100% 0 Mar 1, 2023 Common Stock 27K $8.05 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Award +27K 27K Mar 1, 2023 Common Stock 27K $8.05 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -250K -100% 0 Mar 1, 2023 Common Stock 250K $1.27 Direct F2
transaction CBUS Stock Option (Right-to-Buy) Award +250K 250K Mar 1, 2023 Common Stock 250K $1.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Debra Frimerman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
F2 The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.